IBM Opens Watson Health European Center of Excellence
By HospiMedica International staff writers Posted on 21 Apr 2016 |

Image: IBM CEO Ginni Rometty and Italian Prime Minister Matteo Renzi witness the signing of the agreement for the planned Watson Health European Center of Excellence (Photo courtesy of IBM).
The IBM (Armonk, NY, USA) Watson Health analytics unit has announced it will open its first European Center of Excellence in Milan (Italy).
The Watson Health European Center of Excellence, part of a long-term collaboration between IBM and the government of Italy, will be located near the Human Technopole Italy 2040 research campus, supporting Italy's initiative to establish an international hub for the advancement of genomics, big data, aging, and nutrition. The formation of the Watson Health European Center of Excellence is also intended to encourage the development of a Pan-European ecosystem for healthcare reform, research, and health-tech start-ups.
IBM plans to invest up to USD 150 million during the coming years to bring together data scientists, engineers, researchers, and designers, who will work in collaboration with organizations across Europe to create a new class of cloud-based connected solutions at the intersection of cognitive computing, life sciences, and healthcare. The Center will provide access to resources and technology that can accelerate research into new treatment options, promote personalized medicine, and encourage discoveries aimed at improving overall public health management, while advancing sustainable health systems.
“Italy is important to IBM, not only because of the creativity, skills and talent of the country's workforce, but also because of the Government's efforts to digitize Italy's economy,” said Erich Clementi, senior vice president of IBM Europe. “That is why we are excited to announce our new Watson Health European Center of Excellence near Milan, which will support the Italian Government's healthcare reform and research agenda by bringing together Watson developers and IBM Research scientists to apply remarkable cognitive computing capabilities to modern healthcare problems.”
“Healthcare is undergoing tremendous change, driven by data. The volume and variation of health data is growing exponentially with each passing day and our ability to monitor new measurements of health, such as social data and weather data, are making global health an even more complex equation to solve,” said Deborah DiSanzo, general manager for IBM Watson Health. “This new era in health will not be achieved through solitary efforts. It will require the work of countless experts together in an ecosystem where ideas are easily shared to improve and save lives around the world.”
The Watson Health European Center of Excellence builds on recent IBM investments in Italy and across Europe, including a new IBM Cloud data center in Milan (Italy), and the opening of the Watson Internet of Things (IoT) Global Headquarters in Munich (Germany).
Related Links:
IBM
The Watson Health European Center of Excellence, part of a long-term collaboration between IBM and the government of Italy, will be located near the Human Technopole Italy 2040 research campus, supporting Italy's initiative to establish an international hub for the advancement of genomics, big data, aging, and nutrition. The formation of the Watson Health European Center of Excellence is also intended to encourage the development of a Pan-European ecosystem for healthcare reform, research, and health-tech start-ups.
IBM plans to invest up to USD 150 million during the coming years to bring together data scientists, engineers, researchers, and designers, who will work in collaboration with organizations across Europe to create a new class of cloud-based connected solutions at the intersection of cognitive computing, life sciences, and healthcare. The Center will provide access to resources and technology that can accelerate research into new treatment options, promote personalized medicine, and encourage discoveries aimed at improving overall public health management, while advancing sustainable health systems.
“Italy is important to IBM, not only because of the creativity, skills and talent of the country's workforce, but also because of the Government's efforts to digitize Italy's economy,” said Erich Clementi, senior vice president of IBM Europe. “That is why we are excited to announce our new Watson Health European Center of Excellence near Milan, which will support the Italian Government's healthcare reform and research agenda by bringing together Watson developers and IBM Research scientists to apply remarkable cognitive computing capabilities to modern healthcare problems.”
“Healthcare is undergoing tremendous change, driven by data. The volume and variation of health data is growing exponentially with each passing day and our ability to monitor new measurements of health, such as social data and weather data, are making global health an even more complex equation to solve,” said Deborah DiSanzo, general manager for IBM Watson Health. “This new era in health will not be achieved through solitary efforts. It will require the work of countless experts together in an ecosystem where ideas are easily shared to improve and save lives around the world.”
The Watson Health European Center of Excellence builds on recent IBM investments in Italy and across Europe, including a new IBM Cloud data center in Milan (Italy), and the opening of the Watson Internet of Things (IoT) Global Headquarters in Munich (Germany).
Related Links:
IBM
Latest Health IT News
Channels
Critical Care
view channel
New Prostate Screening Device Could Replace Traditional Examination Method
Prostate cancer is a leading health concern, with one in seven men being diagnosed with the disease. Early detection is critical for improving patient outcomes, but traditional diagnostic methods, such... Read more
Adaptive Spine Board to Revolutionize ER Transport
Prolonged immobilization during transport, such as in combat zones or emergency rescues, poses a life-threatening risk for patients, particularly from pressure injuries. Pressure injuries, also known as... Read moreSurgical Techniques
view channel
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read more
New Surgical Microscope Offers Precise 3D Imaging Using 48 Tiny Cameras
Surgeons have long relied on stereoscopic microscopes to gain depth perception during delicate procedures, but this method has limitations. While these microscopes provide a sense of three-dimensionality,... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more